Rolf K. Hoffmann serves as Executive at Paratek Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Rolf K. Hoffmann has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 21, 2023 involved selling 64,000 shares valued at $0.
Rolf K. Hoffmann currently holds 20,000 shares of Paratek Pharmaceuticals, Inc. (PRTK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rolf K. Hoffmann has been a net neutral trader of PRTK stock. They have purchased $0 and sold $0 worth of shares.
Rolf K. Hoffmann's most recent insider trade was on Sep 21, 2023, when they sold 64,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 8, 2023 | PRTK | $0 | Award | 20,000 | $N/A | Discretionary |
| Feb 16, 2022 | PRTK | $0 | Award | 20,000 | $N/A | Discretionary |
| Feb 18, 2021 | PRTK | $0 | Award | 9,000 | $N/A | Discretionary |
| Feb 19, 2020 | PRTK | $0 | Award | 9,000 | $N/A | Discretionary |
| Feb 26, 2019 | PRTK | $0 | Award | 7,500 | $N/A | Discretionary |
| Apr 30, 2018 | PRTK | $0 | Award | 15,000 | $N/A | Discretionary |